SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001562180-21-006800
Filing Date
2021-11-03
Accepted
2021-11-03 16:45:21
Documents
2
Period of Report
2021-11-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 3  
1 PRIMARY DOCUMENT primarydocument.xml 3 1708
2 POA poa_rfrieson.txt EX-24 3455
  Complete submission text file 0001562180-21-006800.txt   6490
Mailing Address 245 FIRST STREET CAMBRIDGE MA 02142
Business Address 245 FIRST STREET CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Issuer) CIK: 0001517022 (see all company filings)

IRS No.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 245 FIRST STREET 14TH FLOOR CAMBRIDGE MA 02142
Business Address
FRIESON RON (Reporting) CIK: 0001890219 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36352 | Film No.: 211376178